Boston Scientific's struggle with obesity

There are currently only six medical technologies approved by the FDA to help obese people lose weight, and, having bid $615m for Apollo Endosurgery last week, Boston Scientific will soon own two of them. However, last year saw the market entry of a powerful weight loss drug, Novo Nordisk’s Wegovy, and approval of another, Lilly’s Mounjaro, is in the offing.